About Osaka Pharmaceuticals Private Limited
Data last updated:
Osaka Pharmaceuticals Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 March 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ2004PTC043750. Its GSTIN is 24AAACO6725F1ZO (Gujarat). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹9 Cr and a paid-up capital of ₹3 Cr. It is led by directors Monika Sachin Bhandari and Sachin Subhashchandra Bhandari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Old N.H. No – 8, Vadodara, Gujarat, India – 391350.
As per the financials filed for FY 2025, the company reported a revenue of ₹24.38 Cr, a growth of 53% compared to the previous year. For the same year it recorded a net profit of ₹2.78 Lakh (net margin 0.1%) and EBITDA of ₹97.36 Lakh (EBITDA margin 4%).
The company has about 22 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Osaka Pharmaceuticals. As per MCA filings, the company has open charges of ₹81.61 Cr and satisfied charges of ₹86.61 Cr on record. Court records list 19 cases involving the company, including 8 filed by the company and 11 filed against it; 3 cases are pending. The company has 7 deals on record (3 funding rounds, 3 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹21.13 Cr; the latest was in March 2024. Its 10 peer companies in the Pharma industry (Formulations, Pharmaceuticals) are compared by revenue, 5 larger and 5 smaller; the largest is Carewell Steuart Pharma Private Limited with revenue of ₹24.5 Cr.
The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website osakapharmaceutical.com.
Company details
Contact details
Osaka Pharmaceuticals Private Limited's registered office is in Vadodara, Gujarat. Its website is osakapharmaceutical.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressOld N.H. No – 8, Vadodara, Gujarat, India – 391350
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Osaka Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Osaka Pharmaceuticals operates one associated brand: Osaka Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical development, manufacturing, and global distribution in India. | osakapharmaceutical.com |
Financials of Osaka Pharmaceuticals Private Limited
FY 2025 filings availableOsaka Pharmaceuticals Private Limited reported revenue of ₹24.38 Cr (up 53% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 53% in the latest year. EBITDA rose 33% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹97.36 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.78 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Osaka Pharmaceuticals Private Limited, buy the company report.
Board of directors of Osaka Pharmaceuticals Private Limited
Osaka Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Monika Sachin Bhandari | Director | 17 May 2023 | 3 Years 5 Months | Current |
| Sachin Subhashchandra Bhandari | Director | 17 May 2023 | 3 Years 5 Months | Current |
Peer comparison
Osaka Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Carewell Steuart Pharma Private Limited | ₹24.5 Cr (FY 2025) | 79.0% | Tiruvallur, Tamil Nadu, India | |||
| MRHM Pharma Private Limited | ₹24.46 Cr (FY 2024) | 10.0% | Bangalore, Karnataka, India | |||
| Sunberg Life Sciences Private Limited | ₹24.43 Cr (FY 2025) | 92.0% | Chennai, Tamil Nadu, India | |||
| Axon Drugs Private Limited | ₹24.4 Cr (FY 2024) | 4.0% | Chennai, Tamil Nadu, India | |||
| Shri Ganesh Associates Pharmaceuticals Private Limited | ₹24.38 Cr (FY 2025) | 22.0% | Chennai, Tamil Nadu, India | |||
| Osaka Pharmaceuticals Private Limitedthis company | ₹24.38 Cr (FY 2025) | ₹2.78 Lakh | 0.1% | 53.0% | 22 | Vadodara, Gujarat, India |
| Kemecos India Pvt Ltd | ₹24.35 Cr (FY 2025) | 4.0% | Kolkata, West Bengal, India | |||
| Aeon Formulations Private Limited | ₹24.33 Cr (FY 2025) | -16.0% | Chennai, Tamil Nadu, India | |||
| Jinendra Qualipharm Private Limited | ₹24.3 Cr (FY 2025) | 32.0% | Mumbai, Maharashtra, India | |||
| Medior Healthcare Private Limited | ₹24.3 Cr (FY 2025) | -19.0% | Ahmedabad, Gujarat, India | |||
| Axacus Pharma Private Limited | ₹24.29 Cr (FY 2024) | 37.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Osaka Pharmaceuticals Private Limited, buy the company report.
Auditor
Osaka Pharmaceuticals Private Limited is audited by MUKUND & ROHIT for the financial year 2015.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MUKUND & ROHIT | FY 2015 | 113375W |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Jul 2014 | 10520771 | Electronica Finance Limited | ₹14.25 Lakh | Satisfied | |
| 08 Jun 2013 | 10435011 | Oriental Bank of Commerce | ₹3.5 Cr | Satisfied | |
| 27 Dec 2011 | 10326379 | Oriental Bank of Commerce | ₹26.68 Cr | Satisfied | |
| 09 Jun 2011 | 10295172 | Oriental Bank of Commerce | ₹4 Cr | Satisfied | |
| 09 Jun 2011 | 10295179 | Oriental Bank of Commerce | ₹20.6 Cr | Satisfied |
To see the full charge records of Osaka Pharmaceuticals Private Limited, buy the company report.
Total charge records: 8 View all charges
Deals & funding
Osaka Pharmaceuticals Private Limited has 7 deals on record (3 funding rounds, 3 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹21.13 Cr; the latest was in March 2024.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Funding round | ₹3 Cr | Investors: 4 individuals |
| Mar 2012 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Colorama Pharmaceuticals Limited |
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Vidhya Pharmachem Private Limited , Atlantis Lifesciences Private Limited |
| Mar 2011 | Funding round | ₹4.95 Cr | Investors: Atlantis Lifesciences Private Limited, Vidhya Pharmachem Private Limited |
| Mar 2010 | Secondary share transfer | Undisclosed | Seller: Colorama Pharmaceuticals Limited, 3 individuals |
To see the full deal history of Osaka Pharmaceuticals Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Osaka Pharmaceuticals Private Limited has 19 court cases on record: 8 filed by Osaka Pharmaceuticals, 11 filed against it. 3 cases are pending and 16 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 8 | 1 | 2 |
| District courts | 6 | 6 | 1 |
| High courts | 3 | 2 | 0 |
| Supreme Court | 1 | 1 | 0 |
| NCLAT | 1 | 1 | 0 |
Cases on record (5 of 19)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed against the company by Ms Abil Chempharma Pvt Ltd | Pending |
| Bombay High Court | Arbitration matter | Filed against the company by Galpha Laboratories Ltd | Disposed |
| District court, Vadodara, Gujarat | Criminal complaint | Filed against the company by M/S Century Pharmaceuticals Ltd Through Balkrishna A Shetty | Disposed |
| District court, Ahmedabad, Gujarat | Court case (SMST R) | Filed against the company by Rachna Air Components Pvt. Ltd. Through Its Authorized Person Trivedi Nimesh Hashmukhrai | Disposed |
| Supreme Court | Court case (1006-Company Law, Mrtp, Trai, Sebi, Idrai & Rbi : Others) | Filed against the company by Vidhya Pharmachem Pvt. Ltd, | Disposed |
To see the full case history of Osaka Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Osaka Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Osaka Pharmaceuticals Private Limited has a workforce of 22 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
GST
Osaka Pharmaceuticals has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACO6725F1ZO | Gujarat | Active | 01 Jul 2017 |
| 27AAACO6725F1ZI | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Osaka Pharmaceuticals Private Limited, buy the company report.
Recent activity
Osaka Pharmaceuticals Private Limited has 7 board changes on record since 2013: 2 appointments and 5 cessations. The latest: Monika Sachin Bhandari was appointed as Director on 17 May 2023.
17 earlier events are in the company report.
Frequently asked questions
Osaka Pharmaceuticals is an active private limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 March 2004 (22+ years old) and is registered under CIN U24231GJ2004PTC043750.
Osaka Pharmaceuticals has 2 current directors:
- Monika Sachin Bhandari - Director
- Sachin Subhashchandra Bhandari - Director
The latest financial statements of Osaka Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Osaka Pharmaceuticals is 24AAACO6725F1ZO, registered in Gujarat. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 27AAACO6725F1ZI (Maharashtra).
The CIN (Corporate Identification Number) of Osaka Pharmaceuticals is U24231GJ2004PTC043750. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Osaka Pharmaceuticals has 19 court cases on record: 8 filed by the company and 11 filed against it. 3 are pending. Most are in the nclt.
Osaka Pharmaceuticals was incorporated on 09 March 2004, making it 22+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Osaka Pharmaceuticals has 7 deals on record (3 funding rounds, 3 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹21.13 Cr; the latest was in March 2024.
The peers of Osaka Pharmaceuticals by revenue are Carewell Steuart Pharma Private Limited, MRHM Pharma Private Limited, Sunberg Life Sciences Private Limited, Axon Drugs Private Limited, Shri Ganesh Associates Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Monika Sachin Bhandari was appointed as Director on 17 May 2023. Rajen Dasharathlal Kacheria ceased to be Whole-Time Director on 17 May 2023. Sachin Subhashchandra Bhandari was appointed as Director on 17 May 2023. Osaka Pharmaceuticals has 7 board changes on record in total.
Osaka Pharmaceuticals can be reached through the website osakapharmaceutical.com. Its registered office is in Vadodara, Gujarat, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
